`
`(PATENT)
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In re Patent Application of:
`Gregory D. Jay et al.
`
`Application No.: 15/808,632
`
`Confirmation No.: 8457
`
`Filed: November 9, 2017
`
`Art Unit: 1658
`
`For: PRG4 FOR TREATING GOUT AND ITS
`
`Examiner: L. N. Komatsu
`
`SYMPTOMS
`
`Filed Via EFS-Web
`
`INFORMATION DISCLOSURE STATEMENT {IDS}
`
`Pursuant to 37 C.F.R. §§ 1.56, 1.97, and 1.98, the attention of the United States Patent
`
`and Trademark Office is hereby directed to the references listed on the attached PTO/SB/O8. It is
`
`respectfully requested that the information be expressly considered during the prosecution of the
`
`above-identified application, and that the references be made of record therein and appear among
`
`the “References Cited” on any patent to issue therefrom.
`
`This Information Disclosure Statement is filed more than three months after the filing
`
`date of this application, OR more than three months after the date of entry of the national stage in
`
`the international application, AND after the mailing date of a first Office Action on the merits, but
`
`before the mailing date of any of a Final Action under 37 C.F.R. § 1.113, a Notice of Allowance
`
`under 37 C.F.R. § 1.311 or an action that otherwise closes prosecution in this application (37
`
`C.F.R. § 1.97(c)).
`
`In accordance with 37 C.F.R. § 1.98(a)(2)(ii), copies of US. patents and US. patent
`
`application publications are not submitted. Submitted herewith are copies of foreign patents and
`
`non-patent literature in accordance with 37 C.F.R. § 1.98(a)(2).
`
`In accordance with 37 C.F.R. § 1.98(d)(1) and as noted by a double-asterisk next to the
`
`Cite No. on the attached PTO/SB/O8, copies of B1-B20 and C1-C47 are not supplied because they
`
`
`
`Application No.: 15/808,632
`
`2
`
`Docket No.: LUB-030
`
`were previously cited by or submitted to the Office in prior application number 15/546, 192 filed
`
`July 25, 2017 and relied on in the above-identified application for an earlier effective filing date
`
`under 35 U.S.C. § 120.
`
`The Applicant would like to advise the Examiner of the following patents and co-
`
`pending applications, including the contents of the file wrapper, claims, and any Office Actions or
`
`Notices of Allowances issued therein, as these applications/patents contain subject matter that may
`
`be related to the present application. By bringing these applications/patents to the Examiner’s
`
`attention, Applicant does not waive the confidentiality provisions of 35 U.S.C. § 122. Further,
`
`copies of any unpublished co-pending applications that have been scanned to the Image File
`
`Wrapper system and are available via PAIR are not provided as the Office has waived the
`
`requirement under 37 C.F.R. § 1.98(a)(2)(iii) for submitting copies of said applications.
`
` LUB-024
`
`Use of PRG4 as
`an Anti-
`
`Inflammatory
`
`15/546,192
`
`7/25/2017
`
`Jay et al.
`
`It is submitted that the Information Disclosure Statement is in compliance with
`
`37 C.F.R. § 1.98, and the Examiner is respectfully requested to consider the listed references.
`
`Please charge our Credit Card in the amount of $120.00 covering the fee set forth in
`
`37 C.F.R. § 1.17(p). The Director is hereby authorized to charge any deficiency in the fees filed,
`
`asserted to be filed or which should have been filed herewith to our Deposit Account No. 07-1700,
`
`under Order No. LUB-030.
`
`Dated: October 8, 2019
`
`Respectfully submitted,
`
`Tel. No.: 617-570-1513
`Fax No.: 617-523-1231
`
`IPTS/100959737.1
`
`/Cflstal A. Komm/
`Crystal A. Komm
`Registration No.: 67,343
`GOODWIN PROCTER LLP
`
`100 Northern Avenue
`
`Boston, Massachusetts 02210
`
`